Some indicators of hemostasis in patients with ischemic heart disease and coronary angioplasty

Abstract

The effect of hemostasis parameters on the development of stent restenosis / thrombosis requires further investigation. The purpose of the paper is to find out the informativeness of activators and inhibitors of the circulating blood system as markers for the development of thrombotic complications in patients with ischemic heart disease and coronary angioplasty. 92 patients (78 men and 14 women) with ischemic heart disease and coronary angioplasty were examined, of which 33 cases suffered from stent restenosis/thrombosis. The patients were simultaneously evaluated for hemostasis parameters (soluble fibrin, D-dimer, protein C, and fibrinogen). It is determined that in patients with ischemic heart disease who have undergone angioplasty in 67.4% of cases there is a significant increase in the level of soluble fibrin with subsequent significant increase in patients with a history of restenosis. It is established that the level of D-dimer in these patients is significantly lower, while in the women it is significantly lower than that of the studied men. The reaction of anticoagulant protein C in 42.4% of patients tends to decrease, taking into consideration that in 80.4% cases there is significant fibrinogenemia. Therefore, the study reveals a significant imbalance in the system of pro- and anticoagulation in this category of patients in favor of the coagulation link, and the hemostatic parameters studied in the complex can be used as informative integral markers of thrombinemia.